April’s Cambridge New Therapeutics Forum meeting
For the second event, CamNTF will be joined by Dr Xavier Jacq, Head of Biology (MISSION Therapeutics), an experienced drug discovery project manager and expert in protein ubiquitylation and Dr Klaus Okkenhaug, Group Leader (Babraham Institute), an immunologist with particular interests in cell signalling and PI3-kinases. Programme: 17.30 Doors open 18.00 PI3K signalling and activated...